Showing posts with label overview. Show all posts
Showing posts with label overview. Show all posts
Thursday, April 19, 2012
Emerging Therapies for Ovarian Cancer - Chemotherapy Advisor
Emerging Therapies for Ovarian Cancer - Chemotherapy Advisor
Bevacizumab
Other Antiangiogenesis Agents
Poly(ADP-ribose) Polymerase Inhibitors
Other Novel Agents in Ovarian Cancer
printer-friendly (view all on one page): link
Tuesday, February 22, 2011
Feb 21st, 2011: Ovarian cancer - Cancer Network (worth reading/overview of ovarian cancer)
Note: good overview of ovarian cancer biology, treatments, genetics, diet, environment, hormonal factors...
By Stephen C. Rubin, MD, Paul Sabbatini, MD, and Akila N. Viswanathan, MD, MPH | February 21, 2011
Tuesday, September 28, 2010
Tuesday, June 15, 2010
Commentary: June 14th: Personalizing Therapy for Ovarian Cancer: BRCAness and Beyond -- Bast and Mills, 10.1200/JCO.2010.28.5791 -- Journal of Clinical Oncology
Note: links directly to pdf article/overview of ovarian cancer treatments including PARPs, Avastin, Tamoxifen, AZ6244..
"If we are to progress at an optimal pace, accrual of a larger fraction of patients to clinical trials will be essential, requiring referral of ovarian cancer patients to major centers at first recurrence of their disease."
Subscribe to:
Posts
(
Atom
)
